The Hepatology Specialty is one of 30 specialties which bring together communities of clinical practice to provide national networks of research expertise. It is made up of research-interested clinicians and practitioners at both national and local levels. Our job is to ensure that the hepatology studies that are included in our national portfolio of research receive the right support to ensure they are delivered successfully in the NHS.
About Hepatology research
We oversee research that deals with the diagnosis and management of patients with diseases of the liver, biliary tree, and pancreas. This means that we support a wide range of research studies such as those involving acute and chronic liver disease, liver fibrosis and cirrhosis, screening and treating viral hepatitis and genetic studies including pharmacogenetics.
Patient, Carer and Public Information
Patients are at the centre of our work. As a patient, carer or as a member of the public you can get involved by taking part in research, or by helping to shape research.
Hepatology research covers all diseases of the liver and biliary tree. Conducting clinical research across these disease areas can be complex. Despite this, real progress has been made in recent years. This article reflects on that progress and shines a spotlight on recent breakthroughs in hepatitis C research.
Areas such as cancer, stroke and diabetes remain high on the research agenda. But what about medical specialties such as surgery, critical care and hepatology? Network Specialties have harnessed research enthusiasm and expertise in these areas - with impressive results...
Existing Portfolio enquiries - Anaesthesia, perioperative medicine and pain management, Critical care, Injuries and emergencies, Surgery, Ear, nose and throat, Infectious diseases and microbiology, Ophthalmology, Respiratory disorders, Gastroenterology and Hepatology
Enquiries about existing studies on the NIHR CRN Portfolio
General enquiries - Hepatology
New portfolio enquiries
Initial enquiries about the NIHR CRN Portfolio
Enquiries from the life-sciences industry